Role of tumor cells contaminating the graft in breast cancer recurrence after high-dose chemotherapy
- 1 July 1997
- journal article
- case report
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 20 (2) , 167-169
- https://doi.org/10.1038/sj.bmt.1700854
Abstract
One of the possible drawbacks to autologous stem cell transplantation in breast cancer (BC) patients is the potential for tumor contamination in the transplanted product. We present a patient with advanced disease who received high-dose chemotherapy (HDC) and PBPC support as consolidation therapy after achieving complete remission with standard-dose first-line treatment, and suffered recurrence of the disease 6 months after transplantation. Retrospective analysis revealed the presence of contaminating cells in the leukapheretic product, and clinical evidence suggested a role for these cells in the tumor relapse.Keywords
This publication has 0 references indexed in Scilit: